1. Home
  2. ATYR vs FRAF Comparison

ATYR vs FRAF Comparison

Compare ATYR & FRAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • FRAF
  • Stock Information
  • Founded
  • ATYR 2005
  • FRAF 1906
  • Country
  • ATYR United States
  • FRAF United States
  • Employees
  • ATYR N/A
  • FRAF N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • FRAF Major Banks
  • Sector
  • ATYR Health Care
  • FRAF Finance
  • Exchange
  • ATYR Nasdaq
  • FRAF Nasdaq
  • Market Cap
  • ATYR 126.3M
  • FRAF 127.4M
  • IPO Year
  • ATYR 2015
  • FRAF N/A
  • Fundamental
  • Price
  • ATYR $2.11
  • FRAF $30.20
  • Analyst Decision
  • ATYR Strong Buy
  • FRAF
  • Analyst Count
  • ATYR 4
  • FRAF 0
  • Target Price
  • ATYR $19.25
  • FRAF N/A
  • AVG Volume (30 Days)
  • ATYR 541.3K
  • FRAF 4.3K
  • Earning Date
  • ATYR 11-07-2024
  • FRAF 10-22-2024
  • Dividend Yield
  • ATYR N/A
  • FRAF 4.24%
  • EPS Growth
  • ATYR N/A
  • FRAF N/A
  • EPS
  • ATYR N/A
  • FRAF 3.11
  • Revenue
  • ATYR $588,000.00
  • FRAF $69,344,000.00
  • Revenue This Year
  • ATYR N/A
  • FRAF N/A
  • Revenue Next Year
  • ATYR $2,057.88
  • FRAF N/A
  • P/E Ratio
  • ATYR N/A
  • FRAF $9.72
  • Revenue Growth
  • ATYR N/A
  • FRAF 3.47
  • 52 Week Low
  • ATYR $1.08
  • FRAF $25.11
  • 52 Week High
  • ATYR $2.50
  • FRAF $35.00
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 69.53
  • FRAF 40.72
  • Support Level
  • ATYR $1.83
  • FRAF $29.70
  • Resistance Level
  • ATYR $1.96
  • FRAF $30.73
  • Average True Range (ATR)
  • ATYR 0.09
  • FRAF 0.57
  • MACD
  • ATYR 0.03
  • FRAF -0.09
  • Stochastic Oscillator
  • ATYR 86.27
  • FRAF 27.27

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About FRAF Franklin Financial Services Corporation

Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals, and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.

Share on Social Networks: